Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q2 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
MASI:US | Masimo Corp. | Common share | - | US5747951003 | $119.9 |
Company name | Masimo |
---|---|
Tags | #medtech |
Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment |
Business address | 52 DISCOVERY IRVINE CA 92618 949-297-7000 |
Mailing address | 52 DISCOVERY IRVINE CA 92618 |
Website | www.masimo.com |
Information disclosure | www.sec.gov |